The Journal of Rheumatology Publishing Company Limited

The Journal of Rheumatology Publishing Company Limited is a Canadian publishing company based in Toronto, Ontario, best known as the publisher of The Journal of Rheumatology, a monthly international serial devoted to clinical research in rheumatology and related fields. The journal was first published in 1974 and has since become one of the most widely read and cited specialty publications in its field, distributed both in print and online. The company's flagship title, The Journal of Rheumatology, is edited by Earl D. Silverman and supported by an Editorial Committee and Editorial Board. Each monthly issue carries original clinical research articles, meta-analyses, systematic reviews, editorials, historical vignettes, case reports, and letters, with content spanning drug therapy, patient-reported outcomes, and the discovery of therapeutic targets in the treatment of rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis, and other rheumatic and musculoskeletal diseases. According to The Canadian Essential Journal Study, The Journal of Rheumatology ranks among the top three essential publications for rheumatology, with 74% of rheumatologists considering it an essential journal — making it the top journal in the specialty by that measure. Its influence extends to more than 3,600 subscribers globally and to all active members of the Canadian Rheumatology Association, including rheumatology residents and trainees. The journal receives over 1,600 submissions a year from more than 50 countries and generates thousands of citations annually. As a corporate entity, the company operates as a private publisher rather than a listed public company, and its business is closely tied to the success and reputation of its single flagship journal. Its editorial emphasis on continuity while embracing innovation has kept the title relevant to rheumatologists for more than five decades.

The Journal of Rheumatology Publishing Company Limited is a Toronto-based publisher whose history is inseparable from that of its flagship title, The Journal of Rheumatology. The journal was first published in 1974, at a time when rheumatology was consolidating as a distinct clinical and research specialty and when dedicated, high-quality serials for the field were still relatively few. From its founding, the publication was conceived as an international, monthly serial carrying peer-reviewed clinical research rather than a purely national or society bulletin. Over the following decades the journal established itself as a core reference for rheumatologists. Its editorial model combined original clinical research articles with meta-analyses, systematic reviews, editorials, historical vignettes, case reports, and letters, and it maintained an emphasis on clinical relevance to practicing rheumatologists. This mix, together with a monthly publication rhythm in both print and online formats, helped the title accumulate thousands of citations per year and a global readership. By the 2020s the journal had been published for more than fifty years. The publisher describes its editorial approach as one of continuity while embracing innovation — preserving the journal's established scope and standards while adapting to digital delivery and evolving research methods. The journal is edited by Earl D. Silverman, supported by an Editorial Committee and an Editorial Board, and it receives over 1,600 submissions annually from more than 50 countries. Independent recognition has reinforced the title's standing. According to The Canadian Essential Journal Study, The Journal of Rheumatology ranks among the top three essential publications for rheumatology, and 74% of rheumatologists surveyed considered it an essential journal, making it the top journal in the specialty on that measure. Its reach extends to more than 3,600 subscribers worldwide and to all active members of the Canadian Rheumatology Association, including residents and trainees. The publishing company itself operates as a private Canadian business headquartered in Toronto. Its fortunes remain closely tied to the journal, and its principal strategic task is sustaining the title's relevance and citation impact amid a competitive and rapidly digitizing scholarly publishing landscape.

• 1974

  The Journal of Rheumatology is first published.

• The journal becomes a monthly international serial published in print and online.

• The journal is ranked among the top three essential publications for rheumatology by The Canadian Essential Journal Study.

• The journal marks more than 50 years of continuous publication.

A specialty medical publisher whose flagship journal is ranked among the top essential publications in rheumatology and is considered essential by 74% of rheumatologists.

• The Journal of Rheumatology

  Monthly international peer-reviewed serial covering clinical research in rheumatology and related fields, published in print and online.

1. 1About The Journal of Rheumatology | The Journal of Rheumatologyjrheum.org
2. 2The Journal of Rheumatology Publishing Company Limited - Wikidatawikidata.org